![Thomas Cusack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Cusack
Directeur/Membre du Conseil chez
HERON THERAPEUTICS, INC.
Fortune : 2 059 $ au 31/05/2026
Profil
Thomas Patrick Cusack is currently Managing Director at Starboard Value LP since 2017, a position started in 2011.
Mr. Cusack is also Director at Heron Therapeutics, Inc. starting in 2025.
Formerly, Mr. Cusack was an Analyst at Lehman Brothers Holdings, Inc. in 2008 and an Associate at Barclays Capital, Inc. in 2011.
Mr. Cusack completed undergraduate education at The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 2 367 ( 0 % ) | 2 059 $ | 31/05/2026 |
Postes actifs de Thomas Cusack
| Sociétés | Poste | Début |
|---|---|---|
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/10/2025 |
Starboard Value LP
 Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Analyst-Equity | 01/01/2011 |
Anciens postes connus de Thomas Cusack
| Sociétés | Poste | Fin |
|---|---|---|
Lehman Brothers Holdings, Inc.
 Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Corporate Officer/Principal | 30/09/2008 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/05/2011 |
Formation de Thomas Cusack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
